A method of preventing weakness in a patient with Parkinson's disease or of improving or restoring muscle strength of a patient with Parkinson's disease, comprising the step of administering to said patient an amount of one or more hepatocyte growth factor mimics sufficient to prevent, improve or restore to normal said muscle strength, said one or more hepatocyte growth factor mimics having a general structural formula 1 2 3 where R] is one of an N-acyl group, a substituted or unsubstiruted phenyl, a norleucine group, and an amino acid selected from tyrosine, phenylalanine, aspartic acid, arginine, isoleucine, serine, histidine, glycine, cysteine, methionine, tryptophan, lysine norvaline, ornithine, and s-benzyl cysteine
GHK-Cu: Protects brain cells from oxidative stress, promotes neurogenesis, and enhances cognitive resilience
Healthier eyes
Personalized Treatment Plan Your healthcare provider explains whether vitamin B12 injections are appropriate and how often they may be needed
Glutathione Biosynthesis The concentration of GSH in the cytosol of cells varies from 1 to 10 mM
